View printer-friendly version

Download PDF

Emergent BioSolutions to Release First Quarter 2014 Financial Results and Conduct a Conference Call on May 8, 2014

ROCKVILLE, Md.–(BUSINESS WIRE)–Apr. 23, 2014– Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call at 5:00 pm (Eastern Time) on Thursday, May 8, 2014.

Company management will discuss the financial results for the first quarter of 2014, recent business developments, revenue guidance for the second quarter of 2014, and revenue and net income guidance for full year 2014.

This conference call can be accessed live by telephone or through Emergent’s website:

Live Teleconference Information:
Dial in number: 888-679-8034
(International dial in: 617-213-4847)
Passcode: 77573849

Live Webcast Information:
Visit www.emergentbiosolutions.com
and select the “Investors” section

A replay will be available from 10:00 pm (Eastern Time) on May 8, 2014 through May 22, 2014.Pre-registering for the live call will expedite access and minimize hold times. You will be issued a passcode to bypass the operator and connect directly. To pre-register for the call, visit the following website: https://www.theconferencingservice.com/prereg/key.process?key=P6H8D63V3

Replay Information:
Dial in number: 888-286-8010
(International dial in: 617-801-6888)
Passcode: 27031257

Webcast Archive:
Visit www.emergentbiosolutions.com
and select the “Investors” section

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.About Emergent BioSolutions Inc.

Follow us on twitter: @emergentbiosolu.

Source: Emergent BioSolutions Inc.